James Madara, MD, the CEO of the American Medical Association returns to Health 2.0. In 2015 he talked about the AMA’s wider role in changing American health care, including its founding of Health2047, its partnership with Matter and its role in SMART. But since then, in a widely quoted speech he’s called digital health the “snake oil of the early 21st century.” So does he love us or hate us? Matthew will interview him in a no-holds-barred discussion of the state of play, the role of tech in doctors’ offices and in our lives, and what the Health 2.0 community needs to do to improve. This should be a good one!
Laverne Council is the Chief Information Officer and Assistant Secretary for Information and Technology for the Department of Veterans Affairs. She will speak about the digital future of the VA and how it will improve patient outcomes and overall efficiency.
From choosing a health plan to genomics to activity tracking, radically new tools are available to help us make better choices across all aspects of our lives. This session will focus on the consumerization and disruption of traditional care models, as well as feature the brand new technologies that are transforming the experience of, and empowering, the next gen consumer.
Cheryn Flanagan is the Vice President of Customer Experience at Sequence.
Jani Ahonala will demonstrate how Noona can connect patients with valuable medical information and initiate a direct connection with healthcare providers.
Jani is the Chairman and CEO of Noona Healthcare – an innovative start-up that is revolutionizing cancer care by capturing patient reported outcomes (PRO) through novel digital technologies.
Sunjya Schweig is the Clinic Director at the California Center for Functional Medicine.
With over 18 years’ experience working in various aspects of technology, Val founded two previous startups prior to joining LifeAssist as CEO. He has a diverse background including business development, negotiation, strategic planning, transaction structuring for early stage businesses and public companies.